The story of the billionaire e-commerce tycoon's fall from official favor helps illustrate how rapidly China has transformed under Xi Jinping.
For Julie Zhu's latest contributions to The Japan Times, see below:
The fintech giant is following a highly unusual process that draws on some of the tactics its former parent and affiliate Alibaba Group has previously used.
For three whirlwind days in June, U.S. scientist Zhi Hong went shopping at the Boston Bio Conference to find drugs to fill the pipeline of his 2-week-old drug company. Crammed in tight, four-person booths that executives use for private conversations, the former GlaxoSmithKline PLC executive ...